INS and metabolic syndrome: This poor insulin signalling is a foundational aspect of the pathogenesis of metabolic syndrome, obesity, type 2 diabetes, and most chronic diseases and comorbidities linked with an unhealthy diet, e.g., cardiovascular diseases and cancer [30,31,33].